{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:18:03Z","timestamp":1789402683038,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00415-021-10934-7","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T14:10:45Z","timestamp":1642083045000},"page":"3511-3521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Movement disorders associated with neuronal antibodies: a data-driven approach"],"prefix":"10.1007","volume":"269","author":[{"given":"Andrea","family":"Sturchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok K.","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Barbara","family":"Grimberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Businaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin A.","family":"Vizcarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elhusseini","family":"Abdelghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Balint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3389-136X","authenticated-orcid":false,"given":"Alberto J.","family":"Espay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"issue":"9","key":"10934_CR1","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/mds.27446","volume":"33","author":"V Damato","year":"2018","unstructured":"Damato V, Balint B, Kienzler AK, Irani SR (2018) The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders. Mov Dis Off J Mov Dis Soc 33(9):1376\u20131389. https:\/\/doi.org\/10.1002\/mds.27446","journal-title":"Mov Dis Off J Mov Dis Soc"},{"issue":"1","key":"10934_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/brain\/awx189","volume":"141","author":"B Balint","year":"2018","unstructured":"Balint B, Vincent A, Meinck HM, Irani SR, Bhatia KP (2018) Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology. Brain J Neurol 141(1):13\u201336. https:\/\/doi.org\/10.1093\/brain\/awx189","journal-title":"Brain J Neurol"},{"issue":"6","key":"10934_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3174\/ajnr.A5086","volume":"38","author":"BP Kelley","year":"2017","unstructured":"Kelley BP, Patel SC, Marin HL, Corrigan JJ, Mitsias PD, Griffith B (2017) Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. AJNR Am J Neuroradiol 38(6):1070\u20131078. https:\/\/doi.org\/10.3174\/ajnr.A5086","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10934_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","volume":"12","author":"E Lancaster","year":"2016","unstructured":"Lancaster E (2016) The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol (Seoul, Korea) 12(1):1\u201313. https:\/\/doi.org\/10.3988\/jcn.2016.12.1.1","journal-title":"J Clin Neurol (Seoul, Korea)"},{"key":"10934_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2019.05.023","volume":"67","author":"M Chirra","year":"2019","unstructured":"Chirra M, Marsili L, Gallerini S, Keeling EG, Marconi R, Colosimo C (2019) Paraneoplastic movement disorders: phenomenology, diagnosis, and treatment. Eur J Intern Med 67:14\u201323","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10934_CR6","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097","journal-title":"PLoS Med"},{"issue":"15","key":"10934_CR7","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008\u20132012","journal-title":"JAMA"},{"issue":"2","key":"10934_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ana.24872","volume":"81","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ (2017) Microtubule-associated protein 1B: novel paraneoplastic biomarker. Ann Neurol 81(2):266\u2013277","journal-title":"Ann Neurol"},{"issue":"9","key":"10934_CR9","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1007\/s00415-020-09892-3","volume":"268","author":"L Marsili","year":"2020","unstructured":"Marsili L, Vizcarra JA, Sturchio A, Dwivedi AK, Keeling EG, Patel D, Mishra M, Farooqi A, Merola A, Fasano A, Mata IF, Kauffman MA, Espay AJ (2020) When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis. J Neurol 268(9):3203\u20133211","journal-title":"J Neurol"},{"issue":"Pt 8","key":"10934_CR10","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1093\/brain\/awu142","volume":"137","author":"A Carvajal-Gonz\u00e1lez","year":"2014","unstructured":"Carvajal-Gonz\u00e1lez A, Leite MI, Waters P, Woodhall M, Coutinho E, Balint B, Lang B, Pettingill P, Carr A, Sheerin UM, Press R, Lunn MP, Lim M, Maddison P, Meinck HM, Vandenberghe W, Vincent A (2014) Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain J Neurol 137(Pt 8):2178\u20132192. https:\/\/doi.org\/10.1093\/brain\/awu142","journal-title":"Brain J Neurol"},{"issue":"1","key":"10934_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61(1):25\u201336. https:\/\/doi.org\/10.1002\/ana.21050","journal-title":"Ann Neurol"},{"issue":"1","key":"10934_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.23756","volume":"73","author":"A Boronat","year":"2013","unstructured":"Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J (2013) Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 73(1):120\u2013128. https:\/\/doi.org\/10.1002\/ana.23756","journal-title":"Ann Neurol"},{"issue":"8","key":"10934_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK, Dalmau J (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9(8):776\u2013785. https:\/\/doi.org\/10.1016\/S1474-4422(10)70137-X","journal-title":"Lancet Neurol"},{"issue":"9","key":"10934_CR14","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain J Neurol 133(9):2734\u20132748. https:\/\/doi.org\/10.1093\/brain\/awq213","journal-title":"Brain J Neurol"},{"issue":"11","key":"10934_CR15","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1093\/brain\/awz297","volume":"142","author":"SJ Crisp","year":"2019","unstructured":"Crisp SJ, Dixon CL, Jacobson L, Chabrol E, Irani SR, Leite MI, Leschziner G, Slaght SJ, Vincent A, Kullmann DM (2019) Glycine receptor autoantibodies disrupt inhibitory neurotransmission. Brain J Neurol 142(11):3398\u20133410. https:\/\/doi.org\/10.1093\/brain\/awz297","journal-title":"Brain J Neurol"},{"issue":"5794","key":"10934_CR16","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1126\/science.1129947","volume":"313","author":"Y Fukata","year":"2006","unstructured":"Fukata Y, Adesnik H, Iwanaga T, Bredt DS, Nicoll RA, Fukata M (2006) Epilepsy-related ligand\/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science (New York, NY) 313(5794):1792\u20131795. https:\/\/doi.org\/10.1126\/science.1129947","journal-title":"Science (New York, NY)"},{"issue":"11","key":"10934_CR17","first-page":"3144","volume":"141","author":"M Petit-Pedrol","year":"2018","unstructured":"Petit-Pedrol M, Sell J, Planagum\u00e0 J, Mannara F, Radosevic M, Haselmann H, Ceanga M, Sabater L, Spatola M, Soto D, Gasull X, Dalmau J, Geis C (2018) LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory. Brain J Neurol 141(11):3144\u20133159","journal-title":"Brain J Neurol"},{"issue":"Pt 10","key":"10934_CR18","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/brain\/awt212","volume":"136","author":"SR Irani","year":"2013","unstructured":"Irani SR, Stagg CJ, Schott JM, Rosenthal CR, Schneider SA, Pettingill P, Pettingill R, Waters P, Thomas A, Voets NL, Cardoso MJ, Cash DM, Manning EN, Lang B, Smith SJ, Vincent A, Johnson MR (2013) Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain J Neurol 136(Pt 10):3151\u20133162. https:\/\/doi.org\/10.1093\/brain\/awt212","journal-title":"Brain J Neurol"},{"issue":"5","key":"10934_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.10518","volume":"53","author":"SJ Pittock","year":"2003","unstructured":"Pittock SJ, Lucchinetti CF, Lennon VA (2003) Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 53(5):580\u2013587. https:\/\/doi.org\/10.1002\/ana.10518","journal-title":"Ann Neurol"},{"issue":"8","key":"10934_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","volume":"72","author":"H Ari\u00f1o","year":"2015","unstructured":"Ari\u00f1o H, H\u00f6ftberger R, Gresa-Arribas N, Mart\u00ednez-Hern\u00e1ndez E, Armangue T, Kruer MC, Arpa J, Domingo J, Rojc B, Bataller L, Saiz A, Dalmau J, Graus F (2015) Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies. JAMA Neurol 72(8):874\u2013881. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0749","journal-title":"JAMA Neurol"},{"issue":"4","key":"10934_CR21","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","volume":"267","author":"M Boyko","year":"2020","unstructured":"Boyko M, Au K, Casault C, de Robles P, Pfeffer G (2020) Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol 267(4):1137\u20131146. https:\/\/doi.org\/10.1007\/s00415-019-09686-2","journal-title":"J Neurol"},{"issue":"1","key":"10934_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/1097-0142(19950101)75:1<99::aid-cncr2820750117>3.0.co;2-i","volume":"75","author":"J Dalmau","year":"1995","unstructured":"Dalmau J, Graus F, Cheung NK, Rosenblum MK, Ho A, Ca\u00f1ete A, Delattre JY, Thompson SJ, Posner JB (1995) Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75(1):99\u2013109. https:\/\/doi.org\/10.1002\/1097-0142(19950101)75:1%3c99::aid-cncr2820750117%3e3.0.co;2-i","journal-title":"Cancer"},{"issue":"18","key":"10934_CR23","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y, H\u00f6gl B, Bataller L, Br\u00fcggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Mart\u00ed MJ, Montojo T, P\u00e9rez-P\u00e9rez J, Puertas I, Seitz C, Simabukuro M, T\u00e9llez N, Wandinger KP, Iranzo A, Dalmau J (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88(18):1736\u20131743. https:\/\/doi.org\/10.1212\/WNL.0000000000003887","journal-title":"Neurology"},{"issue":"Pt 10","key":"10934_CR24","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awn183","volume":"131","author":"A Saiz","year":"2008","unstructured":"Saiz A, Blanco Y, Sabater L, Gonz\u00e1lez F, Bataller L, Casamitjana R, Rami\u00f3-Torrent\u00e0 L, Graus F (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain J Neurol 131(Pt 10):2553\u20132563. https:\/\/doi.org\/10.1093\/brain\/awn183","journal-title":"Brain J Neurol"},{"issue":"8","key":"10934_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/acn3.328","volume":"3","author":"A Venkatraman","year":"2016","unstructured":"Venkatraman A, Opal P (2016) Paraneoplastic cerebellar degeneration with anti-Yo antibodies\u2014a review. Ann Clin Transl Neurol 3(8):655\u2013663. https:\/\/doi.org\/10.1002\/acn3.328","journal-title":"Ann Clin Transl Neurol"},{"key":"10934_CR26","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MG, Lancaster E et al (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776\u2013785","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10934-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10934-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10934-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:23:08Z","timestamp":1744154588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10934-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10934"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10934-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MBG, PB, KRD, JAV, EA, NW, and BB have nothing to report. AS is cofounder of REGAIN Therapeutics, owner of a provisional patent on compositions and methods for treatment and\/or prophylaxis of proteinopathies. AKD is supported as a co-investigator by the NIH (1 R21 HL143030-01) and (R21 AI133207) grants. He is also currently serving as a statistician in CPRIT funded studies (PP200006, PP190058, PP180003, and PP170068). MG has received honoraria from Roche. LM has received honoraria from the International Association of Parkinsonism and Related Disorders (IAPRD) Society. He serves on the Editorial board of the Journal of Clinical Movement Disorders. AJE: has received grant support from the NIH and the Michael J Fox Foundation; personal compensation as a consultant\/scientific advisory board member for Abbvie, Neuroderm, Neurocrine, Amneal, Adamas, Acadia, Acorda, Kyowa Kirin, Sunovion, Lundbeck, and USWorldMeds; publishing royalties from Lippincott Williams & Wilkins, Cambridge University Press, and Springer; and honoraria from USWorldMeds, Acadia, and Sunovion. He serves on the editorial boards of the Journal of Parkinson\u2019s Disease, European Journal of Neurology, and JAMA Neurology. He is cofounder of REGAIN Therapeutics, owner of a provisional patent on compositions and methods for treatment and\/or prophylaxis of proteinopathies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}